Background illustration for clinical trials search

Dystrophy Clinical Trials

Browse 486 Dystrophy clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Featured

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

for
Neovascular Age-related Macular Degeneration
Location: Hickory NC, Austin TX
Sponsor: Genentech, Inc.

Sex: All

Age: 50+

Code: NCT04853251

Recruiting
Active & ResponsiveNew

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

for
Facioscapulohumeral Muscular Dystrophy, FSHD
Location: Austin TX
Sponsor: Scholar Rock, Inc.

Sex: All

Age: 18 - 60

Code: NCT07435129

Phase2, Recruiting
Active & ResponsiveNew

Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients

for
Duchenne Muscular Dystrophy, Duchenne Disease,
Location: Gainesville FL
Sponsor: University of Florida

Sex: Male

Age: 6+

Code: NCT07766980

Recruiting
Active & Responsive

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

for
Duchenne Muscular Dystrophy
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: Male

Age: 10+

Code: NCT06124196

Recruiting
Active & Responsive

Trial of Cell Based Therapy for DMD

for
Duchenne Muscular Dystrophy
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06692426

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

for
Duchenne Muscular Dystrophy
Location: Ottawa, Toronto, London, Vancouver
Sponsor: Italfarmaco

Sex: Male

Age: 9 - 17

Code: NCT05933057

Phase3, Recruiting
Active & Responsive

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

for
Spinal Muscular Atrophy Type 3,
Location: Boston MA, New York NY, Palo Alto CA
Sponsor: Columbia University

Sex: All

Age: 5+

Code: NCT06839469

Recruiting
Active & Responsive

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

for
Stargardt Disease, Stargardt Disease 1, Cone Rod Dystrophy,
Location: Boston MA, Baltimore MD, Gainesville FL, Ann Arbor MI,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 5+

Code: NCT06445322

Recruiting
Active & Responsive

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

for
Duchenne Muscular Dystrophy
Location: Toronto, Calgary, Vancouver
Sponsor: Solid Biosciences Inc.

Sex: Male

Age: 7 - 11

Code: NCT07160634

Phase3, Recruiting
Active & Responsive

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

for
Duchenne Muscular Dystrophy (DMD)
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: Male

Age: 8 - 18

Code: NCT07172971

Phase1, Recruiting